XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.702
-0.026 (-3.58%)
At close: Mar 9, 2026, 4:00 PM EDT
0.700
-0.002 (-0.28%)
After-hours: Mar 9, 2026, 7:24 PM EDT
XTL Biopharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | - | -1.03 | -1.78 | -1.35 | 0.44 | -2.95 | |
| Depreciation & Amortization | - | 0.2 | - | 0 | 0 | 0 | |
| Loss (Gain) From Sale of Investments | - | -0.17 | 1.02 | 1.53 | -0.75 | -0.14 | |
| Stock-Based Compensation | - | 0.26 | 0 | 0.01 | 0.04 | 0.05 | |
| Other Operating Activities | - | -1.08 | -0.01 | -1.08 | -0.72 | 2.15 | |
| Change in Accounts Receivable | - | 0.04 | - | - | - | - | |
| Change in Accounts Payable | - | 0.21 | 0.02 | -0.04 | -0.02 | 0.02 | |
| Change in Other Net Operating Assets | - | -0.06 | 0.05 | 0.03 | -0.03 | 0.02 | |
| Operating Cash Flow | - | -1.62 | -0.71 | -0.9 | -1.05 | -0.85 | |
| Capital Expenditures | - | -0.05 | - | - | - | -0 | |
| Cash Acquisitions | - | -0.41 | - | - | - | - | |
| Investment in Securities | - | -0.01 | - | - | - | - | |
| Other Investing Activities | - | 0.03 | 0.04 | 0.04 | 0.01 | 0.03 | |
| Investing Cash Flow | - | -0.84 | 0.04 | 0.04 | 0.01 | 0.03 | |
| Long-Term Debt Repaid | - | -0.01 | - | - | - | - | |
| Net Debt Issued (Repaid) | - | -0.01 | - | - | - | - | |
| Issuance of Common Stock | - | 1.46 | - | - | 0.39 | - | |
| Financing Cash Flow | - | 1.45 | - | - | 0.39 | - | |
| Foreign Exchange Rate Adjustments | - | -0.02 | -0.03 | -0.01 | -0.01 | -0.01 | |
| Net Cash Flow | - | -1.03 | -0.69 | -0.88 | -0.66 | -0.82 | |
| Free Cash Flow | - | -1.67 | -0.71 | -0.9 | -1.05 | -0.85 | |
| Free Cash Flow Margin | - | -370.73% | - | - | - | - | |
| Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Levered Free Cash Flow | - | 0.74 | -0.41 | -0.55 | -0.66 | -0.5 | |
| Unlevered Free Cash Flow | - | 0.76 | -0.41 | -0.55 | -0.66 | -0.5 | |
| Change in Working Capital | - | 0.19 | 0.06 | -0.02 | -0.05 | 0.05 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.